From a pathophysiological perspective, channelopathic mutations in both CaV1.2 and CaV1.3 are known to reduce both VDI and CDI (Dick et al., 2016; Ortner et al., 2020; Bamgboye et al., 2022a). The gene discussed is CACNA1D; the disease is clostridium difficile infection.